HIV Prevention App for Black Women at Risk of HIV
(In-the-kNOW Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a mobile app designed to help Black women reduce their risk of contracting HIV. The app, called in-the-kNOW, will be evaluated for its effectiveness in providing HIV prevention and reproductive health information. Participants will either use the app for four months or participate in a one-time virtual health counseling session. Black women who are HIV-negative, sexually active, and own a smartphone may be suitable for this study, particularly if they reside in certain high-risk areas.
As an unphased trial, this study offers participants the opportunity to contribute to important research that could lead to innovative health solutions for their community.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this app is safe for Black women at risk of HIV?
Research has shown that users generally like mobile apps for HIV prevention, such as the in-the-kNOW app. In one study, users appreciated the app's design and found features like alerts for nearby HIV testing sites helpful. Another study on a similar app demonstrated that it helped young people improve their health related to HIV. These findings suggest that this type of app is safe and well-tolerated, with no reports of harm or negative effects. While specific safety data for the in-the-kNOW app itself is lacking, similar apps have proven beneficial and easy to use without causing harm.12345
Why are researchers excited about this trial?
Researchers are excited about the in-the-kNOW mobile app because it offers a unique approach to HIV prevention for Black women at risk. Unlike traditional methods such as PrEP medications or in-person counseling, this app uses a digital platform to deliver prevention education and support directly to users' smartphones. This method not only enhances accessibility and convenience but also provides tailored information and resources, empowering users to make informed health decisions. By leveraging technology, the app has the potential to reach a broader audience and provide continuous support, making it a promising tool in the fight against HIV.
What evidence suggests that the in-the-kNOW mobile app is effective for HIV prevention?
Research has shown that mobile apps like in-the-kNOW, which participants in this trial may receive, can help prevent HIV among Black women. Studies have examined how these apps assist users in tracking risky behaviors and making better sexual health choices. One study in Georgia focused on enhancing a similar app for Black women in high-risk areas, demonstrating its potential to reduce health inequalities. Feedback from college-aged Black women supports the app’s usefulness, as they find mobile health tools helpful for preventing HIV. These findings suggest that the in-the-kNOW app could be an important tool in lowering HIV risk for Black women.678910
Who Is on the Research Team?
Rasheeta Chandler, PhD, RN
Principal Investigator
Nell Hodgson School of Nursing, Emory University
Are You a Good Fit for This Trial?
This trial is for Black women aged 18-44, living in specific high HIV incident areas, who are sexually active and own an Android smartphone. They must be HIV-negative, meet CDC criteria for PrEP eligibility, not pregnant, able to consent, and understand English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either the in-the-kNOW mobile app or a virtual women's health counseling session for four months
Follow-up
Participants are monitored for app usability, acceptability, and HIV prevention outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Control
- in-the-kNOW mobile app
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Georgia Institute of Technology
Collaborator
Morehouse School of Medicine
Collaborator
National Institute of Mental Health (NIMH)
Collaborator